New Haven-based Biohaven recently added Dr. Nick Kozauer to its executive leadership team. He will serve as senior vice president for clinical development and regulatory strategy.
Dr. Kozauer previously worked at the FDA, where he served in multiple roles, most recently as director of the Division of Neurology 2 in the Office of New Drugs.